Ocean Biomedical, Inc. is a biopharmaceutical company that licenses medical research discoveries from universities and medical centers, primarily Brown University and Rhode Island Hospital, to develop them into commercial products. Its pipeline includes preclinical oncology candidates targeting Chi3L1 for NSCLC and glioblastoma, a fibrosis candidate targeting Chit1 for IPF and HPS, and malaria therapeutic and vaccine candidates targeting PfSEA-1 and PfGARP antigens. All programs are in preclinical stages.
Q2 FY2026 — expected 2026-08-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-04-08 | 2024-12-31 | 0001641172-25-003155 | EDGAR | 165K words |
| 2024-11-25 | 2023-12-31 | 0001493152-24-047661 | EDGAR | 160K words |
| 2023-03-31 | 2022-12-31 | 0001493152-23-010129 | EDGAR | 146K words |
| 2022-01-31 | 2021-12-31 | 0001493152-22-002707 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-05-15 | 2025-03-31 | 0001641172-25-011080 | EDGAR | 34K words |
| 2025-01-13 | 2024-09-30 | 0001493152-25-001880 | EDGAR | 44K words |
| 2024-12-23 | 2024-06-30 | 0001493152-24-051208 | EDGAR | 43K words |
| 2024-12-23 | 2024-03-31 | 0001493152-24-051207 | EDGAR | 41K words |
| 2024-04-15 | 2023-09-30 | 0001493152-24-014679 | EDGAR | 40K words |
| 2023-08-14 | 2023-06-30 | 0001493152-23-028396 | EDGAR | 37K words |
| 2023-05-24 | 2023-03-31 | 0001493152-23-018924 | EDGAR | 50K words |
| 2022-10-17 | 2022-09-30 | 0001493152-22-028552 | EDGAR | 23K words |
| 2022-07-11 | 2022-06-30 | 0001493152-22-019014 | EDGAR | 20K words |
| 2022-04-25 | 2022-03-31 | 0001493152-22-010831 | EDGAR | — |
| 2021-10-18 | 2021-09-30 | 0001493152-21-025691 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-08-05 | 0001641172-25-022271 | EDGAR | 1K words |
| 2025-07-23 | 0001641172-25-020730 | EDGAR | 1K words |
| 2025-07-16 | 0001641172-25-019924 | EDGAR | 1K words |
| 2025-06-13 | 0001641172-25-015129 | EDGAR | 1K words |
| 2025-04-23 | 0001641172-25-005788 | EDGAR | 1K words |
| 2025-04-01 | 0001641172-25-002074 | EDGAR | 1K words |
| 2025-03-26 | 0001641172-25-000747 | EDGAR | 1K words |
| 2025-03-20 | 0001493152-25-011046 | EDGAR | 1K words |
| 2025-03-10 | 0001493152-25-009707 | EDGAR | 1K words |
| 2025-02-26 | 0001493152-25-008395 | EDGAR | 6K words |
108 total filings indexed. 83 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001869974 |
| Ticker | OCEA |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/OCEA (~200 tokens, structured JSON with cryptographic provenance)